Beyond Slowing Cognitive Decline: Patient and Caregiver Perspectives on Alzheimer’s Treatment

Beyond the Boardroom: Barbara Corcoran on Caregiving and Alzheimer Disease

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

Updated Criteria for Diagnosis and Staging of Alzheimer Disease: Recommendations of the International Working Group

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

The CMS GUIDE Model To Support Patients with Dementia and Their Caregivers

The BenfoTeam Clinical Trial: Investigating Benfotiamine as a Potential Therapy for Early Alzheimer Disease

BrainCheck as a Digital Cognitive Assessment Tool

Kramer, Van Dyck

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 3

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 2

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 1

Labcorp's Biomarker Testing for Alzheimer Disease

What Neurologists Should Know About End-of-Life Care Discussions

Insights into the Role of Tau in Alzheimer Disease and Neurodegenerative Disorders

Strategies to Limit ARIA Associated with Alzheimer Disease Treatment

Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemab

Emerging Therapeutic Targets for Alzheimer Disease

Progress in Diagnosis and Management of Neuropsychiatric Symptoms in People Living with Dementia

How Healthcare Providers Can Partner with Caregivers of People Living with Dementia